# Secondary Analysis of Gut Hormones and Inflammatory Cytokines in Fasting Subjects

> **NCT01257841** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Leptin administration
- **BEHAVIORAL:** Fasting

## Key facts

- **NCT ID:** NCT01257841
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01257841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01257841, "Secondary Analysis of Gut Hormones and Inflammatory Cytokines in Fasting Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01257841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*